This week learn more about CDC's strategies to reduce waterborne diseases; the US change to a trivalent influenza vaccine; new data for Merck's pneumococcal vaccine; and how PCR testing can influence a patient diagnosis and outcome.
A Clinician’s Perspective on Rebyota for Recurrent C Diff Treatment
C difficile, Antimicrobials, and the Patients Most Affected
Real World Study of Recurrent Clostridioides difficile Therapy Demonstrates Efficacy, Safety
New Insights into Clostridioides difficile Infection and Vaccine Development
Top 5 Infectious Disease News Stories Week of September 27-October 4
C diff Treatment: Fidaxomicin's Rise as The Preferred Therapy Post-IDSA Guidelines